Sicherheit und Wirksamkeitshinweise zum Off-label-Einsatz von Biologikatherapien nach Versagen konventioneller Therapien bei Patienten mit entzündlich rheumatischen Erkrankungen: Ergebnisse eines nationalen Registers (GRAID2)

Translated title of the contribution: Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy: Data from a nationwide German registry (GRAID2)

F. Proft*, H. Schulze-Koops, M. Grunke, E. Schrezenmeier, F. Halleck, J. Henes, L. Unger, E. Schmidt, C. Fiehn, A. Jacobi, C. Iking-Konert, C. Kneitz, Reinhold Ernst Schmidt, B. Bannert, R. E. Voll, R. Fischer-Betz, I. Kötter, H. P. Tony, J. Holle, M. AringerA. Erler, F. Behrens, G. R. Burmester, T. Dörner

*Corresponding author for this work
2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy: Data from a nationwide German registry (GRAID2)'. Together they form a unique fingerprint.

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science